Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OptimizeRx Q3 Adj EPS $0.09 Up From $0.07 YoY, Sales $16.33M Beat $15.01M Estimate

Author: Benzinga Newsdesk | November 06, 2023 08:01am

OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.09 per share. This is a 28.57 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $16.33 million which beat the analyst consensus estimate of $15.01 million by 8.79 percent. This is a 8.25 percent increase over sales of $15.09 million the same period last year.

Posted In: OPRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist